Boston Tech Funding Radar

Google’s Gemini conducted its first autonomous hacks on three companies during Irregular’s testing, guessing passwords or pulling credentials from...

The Navy is shifting from a fragmented entry process to a funnel that pulls in startups with proven results as enterprise services. It now targets...

Is Massachusetts biopharma entering a durable recovery or a selective rebound?

• Venture funding hit $3.45 billion in H1 2026, up 25% YoY and 25% of...

Frontier AI companies face legal pushback for urging slower development while positioning themselves as safety-focused stewards. Critics see the move as obvious BS that ignored governance risks from inconsistent messaging.

Federal NIST awards of $30M to 12 MEP centers—including Massachusetts—aim to accelerate AI, robotics, and automation adoption among small...

XBI gained +1.3% weekly and +30.4% YTD while S&P and Dow dipped.

• Financing win: Electra raised $350M in an upsized IPO for late-stage immune...

Lovable AI secured $400 million in its Series C round at a $13.3 billion valuation, underscoring investor appetite for AI application tools even as competition intensifies in the space.

YC's latest robotics batch reveals clear momentum in physical AI and industrial automation:

• Real-world data at scale emerges as the core bottleneck,...

Spero Therapeutics, a clinical-stage biopharmaceutical company based in Cambridge, MA, is developing next-generation immunology and inflammation...

Sionna Therapeutics is slashing its workforce by 46% and eliminating the chief business officer role after a Phase 2a setback for SION-719,...

Can embedding Accenture’s Faculty inside Anthropic deliver credible independent oversight without compromising autonomy or confidentiality?

-...

Massachusetts-headquartered biopharma companies raised venture capital in H1 2026 while representing 17% of the US drug development pipeline, reinforcing the state's position as a leading biotech concentration.

AgFunder invests in startups solving limiting factors like labor shortages and biological bottlenecks, rather than broad sectors.

• Labor & Autonomy:...

Manus targets a $4 billion valuation via a $500 million round, testing investor appetite for agentic AI after its Beijing-forced split from Meta. The...

Can Mantic's forecasting edge scale into a durable product and investor moat?

• Performance edge: Topped 2026 Metaculus Cup, outperforming all humans...

Anthropic opened a San Francisco Bay Area wet lab to run physical biology experiments for rare diseases, shifting beyond software-only work.

-...

The Navy's $200 million award to Castelion for Blackbeard production marks a key validation of rapid acquisition pathways that let defense startups...

High valuations don't guarantee founder paydays, panelists at Startup Boston Week 2026 explained while sharing strategies for better deal terms.

Kastle's $24M Series A, led by Insight Partners with YC and others, shows enterprise AI agent traction depends on measurable automation of high-volume...

MIT Cambridge researchers unveiled xvr, an AI technique that adapts to individual patients in five minutes and matches intraoperative X-rays to...